Publications

Peer-reviewed Scientific Publications about Rexin-G™:

Adobe Acrobat PDF Le Morte du Tumour (3.4MB)
International Journal of Oncology 2007 30:1297-1307

Adobe Acrobat PDF A Primer on Pathotropic Medicine (600KB)
FDA Special Centennial Edition 2007:80-83

Adobe Acrobat PDF Pathotropic nanoparticles for cancer gene therapy Rexin-G IV: Three-year clinical experience (1.8MB)
International Journal of Oncology 2006 29:1053-1064

Adobe Acrobat PDF Technology Evaluation: Rexin-G (56.6kb)
Current Opinion in Molecular Therapeautics 2005 7(2):164-169

Adobe Acrobat PDF Molecular Engineering of a "Pathotropic" Targeting for Cancer Gene Therapy (211.2kb)
Bioprocessing Journal Jan/Feb 2004

Adobe Acrobat PDF First clinical experience using a 'pathotropic' injectable retroviral vector (Rexin-G) as intervention for stage IV pancreatic cancer. (213kb)
International Journal of Oncology 2004 24:177-185

Adobe Acrobat PDF Inhibition of Metastatic Tumor growth in nude mice by portal vein infusions of matrix-targeted retroviral vectors bearing a cytocidal cyclin G1 Construct (1.6MB)
Cancer Research 2000 60:3343-3347


Adobe Acrobat Reader You must have Adobe Acrobat Reader to view PDF files. You may download it for free by clicking here.